Gated Resonance Energy Transfer (gRET) Controlled by Programmed Death Protein Ligand 1

Programmed Death Ligand 1 (PD-L1) as a Predictive Biomarker for Pembrolizumab Therapy in Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC)

(2019) Lorena Incorvaia et al.   ADVANCES IN THERAPY

Nanoparticles and cancer therapy: Perspectives for application of nanoparticles in the treatment of cancers

(2019) Ali Aghebati‐Maleki et al.   JOURNAL OF CELLULAR PHYSIOLOGY

PD-L1 Distribution and Perspective for Cancer Immunotherapy—Blockade, Knockdown, or Inhibition

(2019) Yilun Wu et al.   Frontiers in Immunology

Mechanisms Controlling PD-L1 Expression in Cancer

(2019) Jong-Ho Cha et al.   MOLECULAR CELL

PLGA Nanoparticles Codelivering siRNAs against Programmed Cell Death Protein-1 and Its Ligand Gene for Suppression of Colon Tumor Growth

(2019) Seo Young Kwak et al.   MOLECULAR PHARMACEUTICS

The role of PD-L1 expression as a predictive biomarker: an analysis of all US Food and Drug Administration (FDA) approvals of immune checkpoint inhibitors

(2019) Andrew A. Davis et al.   Journal for ImmunoTherapy of Cancer

Predictive Factors for Response to PD-1/PD-L1 Checkpoint Inhibition in the Field of Hepatocellular Carcinoma: Current Status and Challenges

(2019) Zuzana Macek Jilkova et al.   Cancers

Personalized detection of circling exosomal PD-L1 based on Fe3O4@TiO2 isolation and SERS immunoassay

(2019) Yuanfeng Pang et al.   BIOSENSORS & BIOELECTRONICS

Nanotechnology in cancer diagnosis: progress, challenges and opportunities

(2019) Ye Zhang et al.   Journal of Hematology & Oncology

Photothermal-Activatable Fe3O4 Superparticle Nanodrug Carriers with PD-L1 Immune Checkpoint Blockade for Anti-metastatic Cancer Immunotherapy

(2018) Rui Ge et al.   ACS Applied Materials & Interfaces

Inner filter effect-based fluorescent sensing systems: A review

(2018) Shuai Chen et al.   ANALYTICA CHIMICA ACTA

A flow-proteometric platform for analyzing protein concentration (FAP): Proof of concept for quantification of PD-L1 protein in cells and tissues

(2018) Chao-Kai Chou et al.   BIOSENSORS & BIOELECTRONICS

PD-L1 and Emerging Biomarkers in Immune Checkpoint Blockade Therapy

(2018) Tricia R. Cottrell et al.   CANCER JOURNAL

Optical Biosensing System for the Detection of Survivin mRNA in Colorectal Cancer Cells Using a Graphene Oxide Carrier-Bound Oligonucleotide Molecular Beacon

(2018) Katarzyna Ratajczak et al.   Nanomaterials

A SERS microfluidic platform for targeting multiple soluble immune checkpoints

(2018) K.Kamil Reza et al.   BIOSENSORS & BIOELECTRONICS

PD-L1 expression as a predictive biomarker in advanced non-small-cell lung cancer: updated survival data

(2017) Pedro N Aguiar et al.   Immunotherapy

Interaction between fluorescein isothiocyanate and carbon dots: Inner filter effect and fluorescence resonance energy transfer

(2017) Huabing Liu et al.   SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY

Probing Bioluminescence Resonance Energy Transfer in Quantum Rod–Luciferase Nanoconjugates

(2016) Rabeka Alam et al.   ACS Nano

Sensing of survivin mRNA in malignant astrocytes using graphene oxide nanocarrier-supported oligonucleotide molecular beacons

(2016) Magdalena Stobiecka et al.   SENSORS AND ACTUATORS B-CHEMICAL

Structural basis for small molecule targeting of the programmed death ligand 1 (PD-L1)

(2016) Krzysztof M. Zak et al.   Oncotarget

PD-L1 expression as predictive biomarker in patients with NSCLC: a pooled analysis

(2016) Francesco Passiglia et al.   Oncotarget

The Next Immune-Checkpoint Inhibitors: PD-1/PD-L1 Blockade in Melanoma

(2015) Kathleen M. Mahoney et al.   CLINICAL THERAPEUTICS

Modulation of Plasmon-Enhanced Resonance Energy Transfer to Gold Nanoparticles by Protein Survivin Channeled-Shell Gating

(2015) Magdalena Stobiecka et al.   JOURNAL OF PHYSICAL CHEMISTRY B

Stepwise Assembly and Characterization of DNA Linked Two-Color Quantum Dot Clusters

(2015) Kaitlin Coopersmith et al.   LANGMUIR

PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy

(2015) S. P. Patel et al.   MOLECULAR CANCER THERAPEUTICS

Structure of the Complex of Human Programmed Death 1, PD-1, and Its Ligand PD-L1

(2015) Krzysztof M. Zak et al.   STRUCTURE

Novel plasmonic field-enhanced nanoassay for trace detection of proteins

(2013) Magdalena Stobiecka   BIOSENSORS & BIOELECTRONICS

Novel multistep BRET-FRET energy transfer using nanoconjugates of firefly proteins, quantum dots, and red fluorescent proteins

(2013) Rabeka Alam et al.   Nanoscale

Nanoparticles in Cancer Imaging and Therapy

(2012) Leon Smith et al.   Journal of Nanomaterials

Silver–Gold Nanocomposite Substrates for Metal-Enhanced Fluorescence: Ensemble and Single-Molecule Spectroscopic Studies

(2012) Sharmistha Dutta Choudhury et al.   Journal of Physical Chemistry C

Distance-Dependent Metal-Enhanced Intrinsic Fluorescence of Proteins Using Polyelectrolyte Layer-by-Layer Assembly and Aluminum Nanoparticles

(2012) Nuriye Akbay et al.   Journal of Physical Chemistry C

Double-shell gold nanoparticle-based DNA-carriers with poly-l-lysine binding surface

(2011) Magdalena Stobiecka et al.   BIOMATERIALS

Nanomaterials for cancer therapy and imaging

(2011) Ki Hyun Bae et al.   MOLECULES AND CELLS

Resonance elastic light scattering (RELS) spectroscopy of fast non-Langmuirian ligand-exchange in glutathione-induced gold nanoparticle assembly

(2010) Magdalena Stobiecka et al.   JOURNAL OF COLLOID AND INTERFACE SCIENCE

A dimeric structure of PD-L1: functional units or evolutionary relics?

(2010) Yong Chen et al.   Protein & Cell

Ligand exchange effects in gold nanoparticle assembly induced by oxidative stress biomarkers: Homocysteine and cysteine

(2009) Magdalena Stobiecka et al.   BIOPHYSICAL CHEMISTRY

The PD-1/PD-L1 complex resembles the antigen-binding Fv domains of antibodies and T cell receptors

(2008) D. Y.-w. Lin et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Average protein density is a molecular-weight-dependent function

(2004) Hannes Fischer et al.   PROTEIN SCIENCE